Seleccione un Tamaño
Acerca de este artículo
Quality Segment
product line
EMPLURA®
assay
≥99.0% ZnO basis (complexometric), 99.0-100.5% (complexometric)
form
solid
impurities
≤0.2% Substances insoluble in dilute acetic acid
loss
≤0.2% loss on ignition, 700°C
pH
8-9 (20 °C, 100 g/L in H2O, slurry)
mp
888 °C
solubility
0.072 g/L
density
9.53 g/cm3 at 20 °C
bulk density
3500‑3700 kg/m3
storage temp.
2-30°C
SMILES string
[Pb]=O
InChI
1S/O.Pb
InChI key
YEXPOXQUZXUXJW-UHFFFAOYSA-N
Application
- Brassica nigra and Curcuma longa Compounds Affecting Interactions Between Spodoptera exigua and Its Natural Enemies Cotesia flavipes and Podisus maculiventris.: This study investigates the effects of compounds from Brassica nigra and Curcuma longa on the interactions between the pest Spodoptera exigua and its natural enemies. It explores the potential of these compounds in integrated pest management strategies (Tavares et al., 2019).
- Synthesis and characterization of a new nano lead(II) 0-D coordination supramolecular compound: A precursor to produce pure phase nano-sized lead(II) oxide.: This research details the synthesis and characterization of a novel nano lead(II) supramolecular compound. The compound serves as a precursor for producing pure phase nano-sized lead(II) oxide, highlighting its potential applications in nanotechnology and materials science (Fard et al., 2017).
Analysis Note
Substances insoluble in dilute acetic acid: ≤ 0.2 %
Loss on ignition (700 °C): ≤ 0.2 %
Legal Information
Still not finding the right product?
Explore all of our products under Lead(II) oxide
Palabra de advertencia
Danger
Indicaciones de precaución
Hazard Classifications
Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 2 - Lact. - Repr. 1A - STOT RE 1
¿Qué está pasando?
WGK 3
Punto de inflamación (°F)
Not applicable
Punto de inflamación (°C)
Not applicable
Órganos diana
Central nervous system,Kidney,Blood
Códigos de peligro
Clase de almacenamiento
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.


